Search

Now showing items 1-1 of 1

Serum sTWEAK and FGF-23 levels in hemodialysis and renal transplant patients

Naji, HE; Ghorbanihaghjo, A; Argani, H; Raeisi, S; Safa, J; Alirezaei, AH; Rashtchizadeh, N (2017)

Background: Kidney transplantation is the treatment of choice for patients with end-stage renal disease. Objective: To evaluate the changes in serum soluble TNF-like weak inducer of apoptosis (sTWEAK) and fibroblast growth ...